Download DNB 2017 Dec PHARMA PHARMA Paper III Question Paper

Download Diplomate in National Board (DNB) 2017 Dec PHARMA PHARMA Paper III Previous Question Papers

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2017
PHARMACOLOGY
PAPER-III
PHARMA/D/17/34/III
Time: 3 hours
Max. Marksz100
Attempt all questions in order.
Each question carries 10 marks.
Flead the question carefully and answer to the point neatly and legibly.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space
Answer all the parts of a single question together.
Start the question to a question on a fresh page or leave adequate space between
two answers.
0 Draw table/diagrams/?owcharts wherever appropriate.
Write short notes on:
1. a) Chi Square test and its application in 5+5
pharmacological research
b) Principle and method of determinants of sample
size calculations for clinical trials
2. a) Current strategies to overcome antimicrobial 5+5
resistance
b) Pharmacotherapy of osteoporosis
3. a) Mention targeted cancer therapies giving 5+5
examples.
b) Mechanism of action and potential uses of
bevacizumab.
4. a) Enumerate current drugs used for leishmaniasis 5+5
with their merits and demerits
b) Mechanism of action and adverse reaction of
miltefosine
5. a) Enumerate anti?malarial drugs used as radical 4+6
curatives and gametocytocidal
b) Pharmacotherapy of chloroquine resistant malaria
6. a) What are the differences between conventional 5+5
and atypical anti?psychotic agents?
b) Enumerate drugs with their mechanism of action
for cognitive deterioration.
7. a) Write the difference between succinylcholine and 5+5
d?tubocurarine
b) Pharmacotherapy of migraine
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINA T1 0N HALL.

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
DECEMBER 2017
8. a) Enumerate various class of drugs used in cardiac 5+5
arrhythmias.
b) Clinical pharmacology, adverse reactions and
therapeutic uses of sotalol
9. a) Discuss pharmacotherapy of multi?drug resistant 5+5
tuberculosis.
b) Outline mechanisms and adverse effect of drugs
used in leprosy.
10. a) Rational antihypertensive drug combinations. 5+5
b) Role of vasopeptidase inhibitor in cardiac failure.
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINA T1 0N HALL.